Vaxcyte, Inc. (PCVX)
NASDAQ · Healthcare
Vaxcyte, Inc. Long Term Debt 2020–2025
Vaxcyte, Inc. annual long term debt history from 2021 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Vaxcyte, Inc. long term debt as of December 31, 2025: 111.4M, a 70.74% increase year-over-year.
- Vaxcyte, Inc. long term debt for 2025 were 111.4M, a 70.74% increase from 2024.
- Vaxcyte, Inc. long term debt for 2024 were 65.2M, a 194.96% increase from 2023.
- Vaxcyte, Inc. long term debt for 2023 were 22.1M, a 83.78% increase from 2022.
- Vaxcyte, Inc. long term debt for 2022 were 12.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vaxcyte, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $111 |
| 2024 | $65 |
| 2023 | $22 |
| 2022 | $12 |
| 2021 | $12 |
Vaxcyte, Inc. Long Term Debt — FAQ
Vaxcyte, Inc. (PCVX) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCVX's long term debt history?
The chart and table above show Vaxcyte, Inc.'s long term debt by year and by quarter, including the growth rate.